<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>EAPSI:  Understanding Evolution Through Whole Genome Sequence Analysis of Microbial Populations</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>06/01/2010</AwardEffectiveDate>
<AwardExpirationDate>05/31/2011</AwardExpirationDate>
<AwardTotalIntnAmount>5617.00</AwardTotalIntnAmount>
<AwardAmount>5617</AwardAmount>
<AwardInstrument>
<Value>Fellowship Award</Value>
</AwardInstrument>
<Organization>
<Code>01090000</Code>
<Directorate>
<Abbreviation>O/D</Abbreviation>
<LongName>Office Of The Director</LongName>
</Directorate>
<Division>
<Abbreviation>OISE</Abbreviation>
<LongName>Office Of Internatl Science &amp;Engineering</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Anne Emig</SignBlockName>
<PO_EMAI>aemig@nsf.gov</PO_EMAI>
<PO_PHON>7032927241</PO_PHON>
</ProgramOfficer>
<AbstractNarration/>
<MinAmdLetterDate>06/03/2010</MinAmdLetterDate>
<MaxAmdLetterDate>06/03/2010</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.079</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>1015546</AwardID>
<Investigator>
<FirstName>Ryan</FirstName>
<LastName>Tewhey</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Ryan Tewhey</PI_FULL_NAME>
<EmailAddress/>
<PI_PHON>8585545763</PI_PHON>
<NSF_ID>000554602</NSF_ID>
<StartDate>06/03/2010</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Tewhey, Ryan</Name>
<CityName>La Jolla</CityName>
<ZipCode>920371027</ZipCode>
<PhoneNumber/>
<StreetAddress/>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
<CONGRESSDISTRICT>49</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>CA49</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM/>
<ORG_LGL_BUS_NAME/>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Tewhey, Ryan]]></Name>
<CityName>La Jolla</CityName>
<StateCode>CA</StateCode>
<ZipCode>920371027</ZipCode>
<StreetAddress/>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>49</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>CA49</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>7316</Code>
<Text>EAPSI</Text>
</ProgramElement>
<ProgramReference>
<Code>5927</Code>
<Text>EAST ASIA, OTHER</Text>
</ProgramReference>
<ProgramReference>
<Code>5978</Code>
<Text>EAST ASIA AND PACIFIC PROGRAM</Text>
</ProgramReference>
<ProgramReference>
<Code>7316</Code>
<Text>EAPSI</Text>
</ProgramReference>
<Appropriation>
<Code>0110</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2010~5617</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><p>The focus of my research is to understand how human pathogens evolve over time. Insight into this fundamental question will allow a richer understanding of why novel isolates of non-harmful bacteria can appear quickly and be devastating to the public health and how known pathogenic isolates may evolve over time to become hyper virulent and resistant to therapies. To answer these questions we have developed methods to quickly sequence the genomes of these pathogens at an extremely low cost using high-throughput DNA sequencing technology.</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To address these questions I utilized the NSF/EAPSI fellowship to spend a summer in the Laboratory of Dr. Patrick Tan at the Genome Institute of Singapore and the National University of Singapore. Dr. Tan is a leading expert on the pathogenicity of the gram-negative bacterium <em>Burkholderia</em>. <em>Burkholderia</em> <em>pseudomallei</em> is a soil dwelling microbe and the causative agent for melioidosis. To understand why <em>B. </em><em>pseudomallei </em>is severely pathogenic we looked at the genome of a similar microbe <em>Burkholderia</em> <em>thailandensis, </em>which rarely results in severe bacteremia caused by that of is closely related kin <em>B. pseudomallei</em>. In doing so we observed rare cases in which <em>B.</em> <em>thailandensis </em>has acquired a group of genes, known as the CPS cluster, previously implicated in the high pathogenicity of <em>B. pseudomallei</em>. These rare cases were unique in that instead of being soil isolates like most <em>B.</em> <em>thailandensis </em>strains collected. The strains with this CPS cluster were collected from patients in the United States with <em>B.</em> <em>thailandensis </em>infections. Thus a normally non-pathogenic bacteria was being transformed into a pathogenic strain because of the addition of genes from <em>B. </em><em>pseudomallei.</em></p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Our ability to detect this acquisition in a holistic and unbiased way was due to recent advances in genomic technologies. While half my time in Singapore was spent working on the applied project of <em>B.</em> <em>thailandensis </em>the other half of my time was improving existing tools for future studies. These tools are currently being applied by us and other groups to understand additional pathogens such as <em>Staphylococcus aureus</em> and <em>Bacillus cereus</em>, as well as how <em>Bacillus subtilis</em> evolves to become resistant to frontline antimicrobial therapies.&nbsp;</p> <p>&nbsp;</p><br> <p>            Last Modified: 06/22/2011<br>      Modified by: Ryan&nbsp;Tewhey</p> </div> <div class="porSideCol"></div> </div>]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[ The focus of my research is to understand how human pathogens evolve over time. Insight into this fundamental question will allow a richer understanding of why novel isolates of non-harmful bacteria can appear quickly and be devastating to the public health and how known pathogenic isolates may evolve over time to become hyper virulent and resistant to therapies. To answer these questions we have developed methods to quickly sequence the genomes of these pathogens at an extremely low cost using high-throughput DNA sequencing technology.              To address these questions I utilized the NSF/EAPSI fellowship to spend a summer in the Laboratory of Dr. Patrick Tan at the Genome Institute of Singapore and the National University of Singapore. Dr. Tan is a leading expert on the pathogenicity of the gram-negative bacterium Burkholderia. Burkholderia pseudomallei is a soil dwelling microbe and the causative agent for melioidosis. To understand why B. pseudomallei is severely pathogenic we looked at the genome of a similar microbe Burkholderia thailandensis, which rarely results in severe bacteremia caused by that of is closely related kin B. pseudomallei. In doing so we observed rare cases in which B. thailandensis has acquired a group of genes, known as the CPS cluster, previously implicated in the high pathogenicity of B. pseudomallei. These rare cases were unique in that instead of being soil isolates like most B. thailandensis strains collected. The strains with this CPS cluster were collected from patients in the United States with B. thailandensis infections. Thus a normally non-pathogenic bacteria was being transformed into a pathogenic strain because of the addition of genes from B. pseudomallei.              Our ability to detect this acquisition in a holistic and unbiased way was due to recent advances in genomic technologies. While half my time in Singapore was spent working on the applied project of B. thailandensis the other half of my time was improving existing tools for future studies. These tools are currently being applied by us and other groups to understand additional pathogens such as Staphylococcus aureus and Bacillus cereus, as well as how Bacillus subtilis evolves to become resistant to frontline antimicrobial therapies.           Last Modified: 06/22/2011       Submitted by: Ryan Tewhey]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
